Description
Levoride 50 is an ANVIS product labelled as levosulpiride tablets 50 mg. The photographed carton contains three strips of ten tablets, giving 30 tablets per box. Its name, strength and tablet presentation help distinguish this pack from other Levoride products.
Levoride 50 product specification
- Product name: Levoride 50
- Active ingredient: Levosulpiride
- Labelled strength: 50 mg
- Dosage form: Tablets
- Pack presentation: 3 strips × 10 tablets
- Total quantity: 30 tablets
- Brand: ANVIS
Check the full product name and strength against your prescription before use. The 30-tablet quantity describes the contents of the carton. It does not specify a daily dose or the length of treatment. Your clinician should decide those details for your individual circumstances.
General information about levosulpiride
Levosulpiride is a gastrointestinal prokinetic: it increases digestive tract movement. Some authorised medicines containing this ingredient are used for selected problems involving delayed stomach emptying. Approved uses depend on the particular product and country. This general information does not establish the approved indications of Levoride 50.
Levoride 50: important precautions
Do not use levosulpiride during pregnancy or breastfeeding. Before treatment, tell your clinician about epilepsy, heart rhythm problems, other medicines, or possible digestive tract bleeding or obstruction. Avoid alcohol. Do not drive if the medicine affects your alertness.
Reported ingredient risks include sleepiness, involuntary movements, raised prolactin and heart rhythm changes. Seek urgent medical help for fever with muscle stiffness and confusion, or fainting with an irregular heartbeat. Read your own leaflet for the full precautions and side effects.
Product documentation and enquiries
The AEMPS levosulpiride leaflet provides general ingredient information for a different brand and strength. It is not the leaflet for this ANVIS product. For the complete Levoride 50 specification and product-specific instructions, contact ANVIS and quote the name and strength. You can also browse the tablet catalogue for other presentations.

Reviews
There are no reviews yet.